Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 11.78
    Last
  • 0.46  4.06%
    Today's Change
  • 11.32
    Previous Close
  • Today
     
    7.09
    12.11
    52 Week Low - High
8:10 pm ET 3/27/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding44 million
Market Cap$519 million
Return on Equity ttm37.92%
Last DividendSUPN:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.443
EPS: Year Est. 12/15 ttm0.133
 
EPS: Quarterly Actual 12/14 0.08
EPS: Quarterly Est. 3/15 -0.01
 
Price/Earnings ttm26.58
Relative Price/Earnings--
Earnings Growth Rate--
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$122 million
Net Income$20 million
Total Assets$138 million
Employees309
Web Sitewww.supernus.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!